no radiation after pathological complete response

Looking for others in my situation. I have tnbc stage 2b, including 3 positive lymph nodes and maybe one in the tail of the breast. Chemo completely wiped out the cancer in both the breast and lymph nodes. I had double mastectomy and 10 lymph nodes removed. Three radiation oncogists still recommend rads but also said i could go into a trial where i would be randomized to have rads or not due to response from chemo. I would love to avoid rads as i already had it for thyroid cancer and am and only 33. Im also brca1 positive.

Anyone else take the plunge with this trial Or decide to forgo rads altogether? I dont want to find out in five years i did it for nothing! Thanks so much

Comments

  • MinusTwo
    MinusTwo Member Posts: 16,634
    edited January 2017

    Rainy - it's a hard choice. I don't believe I could have passed on rads since I saw personally that there's too much chance of "micro mets" moving through the system. Good luck.

  • Maya15
    Maya15 Member Posts: 323
    edited January 2017

    Hi Rainy,

    I had to make the same choice. We had assumed I would get rads because of the large tumors and positive nodes, but after surgery it turned out the chemo wiped everything out. I was not keen on getting rads because of the side effects, damage and delay to reconstruction, high risk of lymphedema etc. After extensive consultation the radiation oncologists at my cancer center said I could go either way, and offered me participation in the same clinical trial as you mention. I declined because I was not willing to be randomized into the radiation arm. I am 37 and they were tempted to recommend rads because of my age, but they looked at a bunch of studies that showed age is not a factor in recurrence.

    They explained that whatever your risk of recurrence is, rads will lower it by 50%. For me they put the risk low because of the PCR and because I am getting a year of Herceptin/Perjeta on top of the chemo. So for me the benefit was not worth the side effects. They did say that even with a PCR, they will always recommend rads for someone who's triple negative because it's the only weapon they have other than chemo (no hormones or Herceptin etc) so rads make a bigger difference in the recurrence rates for tnbc. But ultimately I think it depends how high your personal risk is and how much risk vs side effects you're willing to put up with.

  • Rainy213
    Rainy213 Member Posts: 9
    edited January 2017

    thanks for your input ladies! Maya i was thinking of going forward with it because it is triple negative like you said so thank you for sharing that...really helped! <3

  • ElaineTherese
    ElaineTherese Member Posts: 3,328
    edited January 2017

    Hi!

    I had rads after neoadjuvant chemo primarily because of the size of my lump (5 cm+). My pathology report found no active cancer, but my team recommended rads because my lump was so big and my cancer was so aggressive (Grade 3, HER2+). If my lump had been smaller, say 2 cm., my doctors might have been less keen on rads.

  • Kat1984
    Kat1984 Member Posts: 47
    edited January 2017

    hiya, I took was triple negative but stage 2a, no lymph nodes effected. I battled with the same decision for quite some time. I had my treatment in a weird order - 4xAC then mastectomy, where I was found to have a pCR, then 12x taxol after that. My doctors were recommended no radiation, they based this on the pCR, additional adjuvent chemo, and the fact my lymph nodes were clear. The only reason they gave in favour of radiation was my age, 30 at diagnosis. They explained that radiation reduced the risk of local reoccurrence only and if I was to forego it, it could be used as a treatment option in the future if need be, as it's a one time only treatment (of each area). I am now 7 months post treatment and recently underwent the first stage of my recon. Life is back to normal. Best of luck with your decision! X

  • VLH
    VLH Member Posts: 1,258
    edited January 2017

    I'm in a similar dilemma as a TNBC woman. I'm having adjuvant chemo (4 AC+ 12 weeks of Taxol) so can't look to a PCR; however, all three nodes were negative and my 2.2 cm tumor barely meet the requirement for Stage II. DCIS was found in the margins at the first lumpectomy so I had a second lumpectomy to remove that and the surgeon got clean margins.

    I'm much older than you at 62 and BRCA negative. Unfortunately my tumor was in my left breast raising more concerns about heart damage. I developed severe cellulitis ultimately requiring two weeks of daily IV antibiotics when the surgeon drained a seroma at the SNB site. I developed mild hand-foot syndrome on my left foot with the AC and a tiny clogged oil gland in my eyelid meant an infection bad enough to delay the start of my Taxol by two weeks.

    With my skin seeming very vulnerable, what will happen with my entire F-G cup breast is irradiated? For my specifics, radiation only affects local recurrence with little to no impact on overall survival, but I'm obviously not eager to have a recurrence resulting in a mastectomy. If I have the radiation and still have a local recurrence, I know irradiated skin presents challenges with reconstruction. I'm also troubled by radiation oncologists seeming to gloss over long-term risks. I was discussing with my MO how they typically only see you for a couple of months, but many on our forum report ongoing or permanent problems related to radiation. This decision it's a challenging one because with TNBC, it's the metastasis to vital organs that kills you, but no one wants the risks and angst of yet another surgery for a local recurrence either. A crystal ball would certainly be helpful!

    Lyn

  • stephincanada
    stephincanada Member Posts: 228
    edited January 2017


    There is a 2015 study that strongly suggests that even where neoadjuvant chemo cuses the tumour to disappear (pathological complete response), the patient should still be treated with radiation:

    Relationship of omission of adjuvant radiotherapy to outcomes of locoregional control and disease-free survival in patients with or without pCR after neoadjuvant chemotherapy for breast cancer: A meta-analysis on 3481 patients from the Gepar-trials.

    http://meetinglibrary.asco.org/content/146776-156

    Note the conclusion: "This retrospective analysis suggests that patients managed without radiotherapy (radiation) after neoadjuvant chemotherapy for breast cancer have a significantly worse outcome even if they achieved a pCR (pathologic complete response)".

    "In patients with pCR, the 5-yr LRFS was 95.7%% with RT vs 86.6% without RT (HR 3.32, 95% CI 1.00-11.08; p = 0.051) and 5-yr DFS was 86.9% with RT and 56.1% without RT (HR 3.52, 95% CI 1.82-6.83; p < 0.001" (thanks to Hernie for this summary)


  • Rainy213
    Rainy213 Member Posts: 9
    edited January 2017

    steph I could kiss you! Thank you.

  • stephincanada
    stephincanada Member Posts: 228
    edited January 2017

    aaaw, thanks, Rainy!! You made my day. So pleased to help!!

Categories